Skip to main content

Advertisement

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Diagnostic testing managed by hematopathology specialty and other laboratories: costs and patient diagnostic outcomes

  • Nicole M Engel-Nitz1, 6Email author,
  • Benjamin Eckert2, 3,
  • Rui Song1,
  • Priyanka Koka1,
  • Erin M Hulbert1,
  • Jeffrey McPheeters1 and
  • April Teitelbaum1, 4, 5
BMC Clinical Pathology201414:17

DOI: 10.1186/1472-6890-14-17

Received: 7 March 2013

Accepted: 17 April 2014

Published: 27 April 2014

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
7 Mar 2013 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
21 Mar 2013 Author responded Author comments - Nicole Engel-Nitz
Resubmission - Version 4
21 Mar 2013 Submitted Manuscript version 4
23 Sep 2013 Reviewed Reviewer Report - Sarah Wordsworth
21 Nov 2013 Reviewed Reviewer Report - John Kalbfleisch
1 Feb 2014 Author responded Author comments - Nicole Engel-Nitz
Resubmission - Version 5
1 Feb 2014 Submitted Manuscript version 5
Publishing
17 Apr 2014 Editorially accepted
27 Apr 2014 Article published 10.1186/1472-6890-14-17

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Optum, Eden Prairie
(2)
Novartis Molecular Diagnostics
(3)
Present address Metamark Genetics
(4)
Present address Heme Onc Associates
(5)
AHT BioPharma Advisory Services
(6)
Health Economics and Outcomes Research, Optum

Advertisement